Biologics Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans byJosh SandbergSeptember 9, 2019
Biologics Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics byJosh SandbergJune 6, 2019
Extremities Finger Joint Swelling May Be a Sign of Knee Osteoarthritis byJosh SandbergJanuary 31, 2019
Biologics Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints byJosh SandbergOctober 25, 2018
Biologics Bone Therapeutics announces single intra-articular injection of viscosupplement JTA-004 delivered higher pain reduction than the reference in first study in knee osteoarthritis byJosh SandbergOctober 17, 2018
Extremities Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis byJosh SandbergJune 19, 2018
Extremities Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain byJosh SandbergFebruary 21, 2018
Sports Medicine Zimmer Biomet Announces Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit byJosh SandbergDecember 26, 2017
Biologics Hospitals Bioventus Receives US FDA Approval for DUROLANE® byJosh SandbergSeptember 5, 2017
